Objective: The main goal of this research is the assessment of sexual dysfunction in a group of OCD patients in Iran. Method: The participants were 36 women and 20 men (between 18 to 50 years old) who suffered from OCD based on both psychiatric interview and DSM-IV questionnaire (SCID). They were referred to Roozbeh Psychiatric Hospital and 3 private clinics in Tehran from 2011 to 2013. The following questionnaires were fi lled in this descriptive cross-sectional study: FSFI, IIEF, MOCI, OCI-R and a demographic questionnaire. Results: Sexual dysfunction is reported in 80.6% of female and 25% of male OCD patients. The percentage of disorders according to all subscales of FSFI, consisting of sexual desire, sexual arousal, lubrication, orgasm, satisfaction and sexual pain, were 50%, 58.3%, 36.1%, 44.4%, 41.7% and 52.8%, respectively. Based on the IIEF subscales, another questionnaire, the frequency of sexual desire, erectile disorder, orgasmic disorder and sexual dissatisfaction were 10%, 20%, 25% and 40%, respectively. Moreover, a statistically signifi cant correlation was found between the total score of OCI-R and erectile and satisfaction subscales of IIEF. In addition, the score of washing in OCI-R and sexual satisfaction in IIEF were signifi cantly correlated. According to the fi ndings of this research, there is a relation between sexual satisfaction and OCD. Conclusion: These fi ndings suggest that certain areas of sexual functioning may be impacted by OCD symptomatology and may in turn have a greater negative impact on quality of life. Therefore the assessment of sexual dysfunction in all OCD patients is suggested.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.